Neiss A - Search Results

1

The burden of varicella in Germany. Potential risks and economic impact.

Banz K, Wagenpfeil S, Neiss A, Hammerschmidt T, Wutzler P. Banz K, et al. Among authors: neiss a. Eur J Health Econ. 2004 Feb;5(1):46-53. doi: 10.1007/s10198-003-0200-7. Eur J Health Econ. 2004. PMID: 15452764

2

The cost-effectiveness of routine childhood varicella vaccination in Germany.

Banz K, Wagenpfeil S, Neiss A, Goertz A, Staginnus U, Vollmar J, Wutzler P. Banz K, et al. Among authors: neiss a. Vaccine. 2003 Mar 7;21(11-12):1256-67. doi: 10.1016/s0264-410x(02)00431-0. Vaccine. 2003. PMID: 12559807

3

Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.

Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H. Wutzler P, et al. Among authors: neiss a. Med Microbiol Immunol. 2002 Oct;191(2):89-96. doi: 10.1007/s00430-002-0123-4. Epub 2002 Aug 29. Med Microbiol Immunol. 2002. PMID: 12410347

4

Validation of health economic models: the example of EVITA.

Hammerschmidt T, Goertz A, Wagenpfeil S, Neiss A, Wutzler P, Banz K. Hammerschmidt T, et al. Among authors: neiss a. Value Health. 2003 Sep-Oct;6(5):551-9. doi: 10.1046/j.1524-4733.2003.65241.x. Value Health. 2003. PMID: 14627061 Free article.

5

Economic evaluation of varicella vaccination programmes: a review of the literature.

Hammerschmidt T, Banz K, Wagenpfeil S, Neiss A, Wutzler P. Hammerschmidt T, et al. Among authors: neiss a. Pharmacoeconomics. 2004;22(2):133-6; author reply136-8. doi: 10.2165/00019053-200422020-00005. Pharmacoeconomics. 2004. PMID: 14731053 Review. No abstract available.

6

[Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].

Knuf M, Neiss A, Wutzler P. Knuf M, et al. Among authors: neiss a. Klin Padiatr. 2006 Jul-Aug;218(4):203-12. doi: 10.1055/s-2005-836610. Klin Padiatr. 2006. PMID: 16819701 German.

7

Empirical data on the varicella situation in Germany for vaccination decisions.

Wagenpfeil S, Neiss A, Banz K, Wutzler P. Wagenpfeil S, et al. Among authors: neiss a. Clin Microbiol Infect. 2004 May;10(5):425-30. doi: 10.1111/j.1469-0691.2004.00853.x. Clin Microbiol Infect. 2004. PMID: 15113320 Free article.

8

Effects of varicella vaccination on herpes zoster incidence.

Wagenpfeil S, Neiss A, Wutzler P. Wagenpfeil S, et al. Among authors: neiss a. Clin Microbiol Infect. 2004 Nov;10(11):954-60. doi: 10.1111/j.1469-0691.2004.01020.x. Clin Microbiol Infect. 2004. PMID: 15521996 Free article.

9

Bootstrap confidence intervals for costs-of-illness of type 2 diabetes mellitus in Germany.

Wagenpfeil S, Neiss A, Goertz A, Reitberger U, Stammer H, Spannheimer A, Liebl A. Wagenpfeil S, et al. Among authors: neiss a. Value Health. 2002 Sep-Oct;5(5):398-404. doi: 10.1046/J.1524-4733.2002.55136.x. Value Health. 2002. PMID: 12201857 Free article.

10

Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany.

Meister W, Neiss A, Gross G, Doerr H, Höbel W, Malin J, von Essen J, Reimann B, Witke C, Wutzler P. Meister W, et al. Among authors: neiss a. Intervirology. 1998;41(6):272-7. doi: 10.1159/000024949. Intervirology. 1998. PMID: 10325537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page